PubMed Health⌕ Search

PubMed · 11195405

NCCN Practice Guidelines for Prostate Cancer.

Abstract

Systemic therapies for prostate cancer are likely to improve, and as they do, they will have enormous impact on the treatment of high-risk and locally advanced cancers. Further technical improvements in radiotherapy and alternative local modalities, such as cryoablation, are also likely, and will bring even more options for local control. It is certain these guidelines will continue to evolve.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

R R Bahnson, G E Hanks, R P Huben, P Kantoff, J M Kozlowski, M Kuettel, P H Lange, C Logothetis, J M Pow-Sang, M Roach, H Sandler, P T Scardino, R J Taylor, D A Urban, P C Walsh, T G Wilson, National Comprehensive Cancer Network. 2000. NCCN Practice Guidelines for Prostate Cancer.. https://pubmed.ncbi.nlm.nih.gov/11195405/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

[Acute and transient psychotic disorders (ICD-10: F23). Empirical data and implications for therapy].

The defining clinical features of acute and transient psychotic disorders (ICD-10: F23) are an acute onset and a duration of psychotic symptoms not exceeding 1-3 months. Previous empirical investigations show that patients with this diagnosis have a favourable prognosis, but also a high risk of relapses (58-77%). The diagnostic stability in the further course of illness seems to be low (34-73%) with a frequent diagnostic change to schizophrenia and affective disorders being observed. As yet, data from controlled clinical trials regarding therapy do not exist. The implications for the treatment of acute and transient psychotic disorders are discussed with this background.

Evidence-Based Medicine↗